Cytophage Technologies Ltd. (TSXV:CYTO)
Canada · Delayed Price · Currency is CAD 0.1050
+0.0100 (10.53%)
At close: Feb 27, 2026
Cytophage Technologies Market Cap
Cytophage Technologies has a market cap or net worth of CAD 7.11 million as of March 2, 2026. Its market cap has decreased by -51.20% in one year.
Market Cap
7.11M
Enterprise Value
8.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.11
Market Cap Chart
Since February 4, 2022, Cytophage Technologies's market cap has increased from 5.25M to 7.11M, an increase of 35.37%. That is a compound annual growth rate of 7.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 7.11M | -30.00% |
| Dec 31, 2025 | 10.15M | -36.19% |
| Dec 31, 2024 | 15.91M | 478.58% |
| Dec 23, 2022 | 2.75M | -47.62% |
| Feb 4, 2022 | 5.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glow Lifetech | 9.08M |
| COSCIENS Biopharma | 8.02M |
| PharmaTher Holdings | 7.28M |
| Kane Biotech | 7.26M |
| Marvel Biosciences | 6.96M |
| BioVaxys Technology | 6.83M |
| Restart Life Sciences | 5.93M |
| Aptose Biosciences | 5.51M |